These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Developing a national system for dealing with adverse events following immunization. Mehta U; Milstien JB; Duclos P; Folb PI Bull World Health Organ; 2000; 78(2):170-7. PubMed ID: 10743281 [TBL] [Abstract][Full Text] [Related]
7. Guidelines for reporting adverse events associated with vaccine products. Division of Immunization, Bureau of Infectious Diseases, Laboratory Center for Disease Control. Can Commun Dis Rep; 2000 Feb; 26 Suppl 1():I-IV, 1-18. PubMed ID: 11055081 [No Abstract] [Full Text] [Related]
8. Monitoring vaccine safety depends on reports from providers. Grabenstein JD J Am Pharm Assoc (Wash); 1999; 39(6):869. PubMed ID: 10609455 [No Abstract] [Full Text] [Related]
9. Presenting the case for an immunization safety surveillance system. Darwish AA Bull World Health Organ; 2000; 78(2):216. PubMed ID: 10743287 [No Abstract] [Full Text] [Related]
10. An analysis of the reactivity of vaccines administered in Texas from 1991 through 1999. Geier DA; Geier MR Tex Med; 2002 Jul; 98(7):50-4. PubMed ID: 12134752 [TBL] [Abstract][Full Text] [Related]
13. Adverse events monitoring as a routine component of vaccine clinical trials: evidence from the WHO Vaccine Trial Registry. Mayans MV; Robertson SE; Duclos P Bull World Health Organ; 2000; 78(9):1167. PubMed ID: 11019467 [No Abstract] [Full Text] [Related]
14. New book about vaccine safety. Offit PA Pediatrics; 2008 Oct; 122(4):871-2. PubMed ID: 18829814 [No Abstract] [Full Text] [Related]
15. [Vaccines' adverse events: questions and answers brought by InfoVac]. Cohen R; Siegrist CA Arch Pediatr; 2006 Jun; 13(6):650-2. PubMed ID: 16690277 [No Abstract] [Full Text] [Related]
16. The development of standardized case definitions and guidelines for adverse events following immunization. Kohl KS; Gidudu J; Bonhoeffer J; Braun MM; Buettcher M; Chen RT; Drammeh B; Duclos P; Heijbel H; Heininger U; Hummelman E; Jefferson T; Keller-Stanislawski B; Loupi E; Marcy SM Vaccine; 2007 Aug; 25(31):5671-4. PubMed ID: 17400339 [No Abstract] [Full Text] [Related]
17. The monitoring of adverse events following immunization. Tatley M N Z Med J; 2002 Nov; 115(1165):U247; author reply U247. PubMed ID: 12552289 [No Abstract] [Full Text] [Related]
18. The role of editorial peer review in the evaluation of vaccine safety. Jefferson T Vaccine; 2004 May; 22(15-16):2073-5. PubMed ID: 15121326 [No Abstract] [Full Text] [Related]
19. Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS). Russell M; Pool V; Kelso JM; Tomazic-Jezic VJ Vaccine; 2004 Dec; 23(5):664-7. PubMed ID: 15542187 [TBL] [Abstract][Full Text] [Related]
20. Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS. ; Expert Rev Vaccines; 2009 Jun; 8(6):705-16. PubMed ID: 19485752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]